Five Purdue Pharma LP patents covering an abuse-resistant OxyContin formulation that reduces the opiod’s toxicity are invalid ...

The most notable decision in the bankruptcy world in 2024 was the Supreme Court’s decision in Purdue Pharma. Harrington v.

BOSTON (AP) — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly ...

As part of the agreement, McKinsey admitted in a court filing that it chose to continue working with Purdue Pharma to improve sales of OxyContin despite knowing the risks of the addictive opioid.

The agreement marks the first time a management consulting firm has been held criminally responsible for advice resulting in ...

Disgraced former OxyContin marketer Purdue Pharma is on the hook for billions after agreeing to settle cases that held the company responsible for fueling the U.S. opioid crisis. Now, the company ...

McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...

States are channeling funds into overdose response equipment, drug identification tools and community recovery initiatives ...

The firm faced charges of conspiracy to defraud the U.S., destroying documents. International consulting firm McKinsey & Company agreed Friday to resolve criminal charges with federal prosecutors ...

Prosecutors say McKinsey “knew the risk and dangers” of OxyContin and knew that Purdue Pharma executives had previously pleaded guilty to crimes related to the promotion of the drug ...